CIDRAP newsletters options
(CIDRAP News) The World Health Organization (WHO) said its team arrived in the Ukraine last night and met with the country's health ministry today to discuss a dramatic spike in flulike illnesses and deaths, particularly in the western part of the country.
Nov 3, 2009
(CIDRAP News) The World Health Organization (WHO) confirmed yesterday that it was sending a team of experts to help the government of Ukraine, where it said more than 2,300 people have been hospitalized for what is suspected to be pandemic H1N1 influenza and 38 have died.
(CIDRAP News) Interim clinical trial findings announced today affirm that children younger than 10 need two pandemic H1N1 vaccine doses, and initial findings in pregnant women reveal no safety concerns and a need for only one dose.
Federal officials also detailed the role of an independent panel of experts to review vaccine safety data and released a report outlining the government's vaccine safety monitoring system.
Canadian advisors push seasonal vaccine
(CIDRAP News) An expert committee that advises the World Health Organization (WHO) today updated its guidance on pandemic H1N1 vaccines, recommending a single dose for most age-groups and advising that any of the forms are safe for pregnant women.
NY declaration expands vaccinator pool
(CIDRAP News) The H1N1 influenza virus is now widespread in all but two states and has claimed the lives of 114 children, 19 more than the toll a week ago, the Centers for Disease Control and Prevention (CDC) reported in an update today.
"Essentially what we see is more virus, more vaccine, and more deaths," CDC Director Dr. Thomas Frieden said at a press briefing.
(CIDRAP News) Ukranian officials today shuttered schools and banned public meeting for the next 3 weeks in the wake of a spike in pandemic flu and the country's first H1N1 deaths, which have sparked speculation that the disease has become worse in some patients or that another pathogen is circulating.
(CIDRAP News) A report from the Centers for Disease Control and Prevention (CDC) estimates that the true number of H1N1 influenza cases in the first 4 months of the epidemic may have been as high as 5.7 million, or more than 100 times the official case count.
(CIDRAP News) Though only available for emergency use, intravenous (IV) antivirals peramivir and zanamivir have been lifesaving for some pandemic H1N1 patients, including two dramatic cases that doctors presented yesterday during a US Centers for Disease Control and Prevention (CDC) conference call for clinicians.
(CIDRAP News) Commonly available drugs that are sold in lower-cost generic versions improve the survival of patients hospitalized for seasonal influenza, researchers reported today, raising the possibility of a widely available treatment that could be used in a severe flu pandemic if other drugs are in short supply.
Flu activity rebounds at many colleges
(CIDRAP News) Some clinicians and public-heath workers are experiencing understandable confusion about the timing of doses for H1N1 and seasonal influenza vaccines, as well as other childhood vaccines, officials at the US Centers for Disease Control and Prevention (CDC) said today in a conference call for health professionals.
Oct 28, 2009
(CIDRAP News) The pandemic H1N1 vaccine supply is increasing significantly, and over the next 2 weeks Americans will have an easier time finding and receiving the doses, the US Centers for Disease Control and Prevention (CDC) said today.
NYC to start school-based vaccines
(CIDRAP News) In a measure designed to help hospitals respond more quickly to surging numbers of pandemic H1N1 cases, President Barack Obama on Oct 24 signed an emergency declaration that will help facilities establish alternative care sites and protocols for triage and transport.
Oct 26, 2009
(CIDRAP News) Requests to use the intravenous (IV) antiviral drug peramivir in hospitalized H1N1 flu patients came quickly after the government issued an emergency use authorization (EUA) Oct 23, a Centers for Disease Control and Prevention (CDC) official said today.
